Zymeworks (ZYME) Misses Q4 EPS, Revenue Beats

Zymeworks (NASDAQ: ZYME) reported Q4 EPS of $4.71, $0.13 worse than the analyst estimate of $4.84. Revenue for the quarter came in at $402.49 million versus the consensus estimate of $371.3 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold